M. Vicky, MCF) (87ème section)

R. Jean-philippe, PR) (69ème section) FRANCESCHI Frédéric (PU-PH)

B. Adriana, MCF) (69ème section) CHIRURGIE DIGESTIVE 5202

A. Zaineh and M. , MCF) (5ème section)

B. Sylvie, MCF) (5ème section) BEGE Thierry (MCU-PH)

B. Evelyne, MCF) 65ème section) (retraite octobre, 2016.

B. Françoise, MCF) 65ème section)

B. Caroline, MCF) (1ère section)

F. Simon, (. Pr, and . Méd, Gén. à mi-temps) BERLAND Yvon (PU-PH)

A. Sébastien, (. Mcf, and . Méd, Gén. à mi-temps) BURTEY Stépahne (PU-PH)

. Bonnet-pierre-andré and . Méd, Gén à mi-temps) MOAL Valérie (PU-PH)

G. Pierre and . Méd, Gén. à mi-temps) JOURDE CHICHE Noémie (MCU PH)

R. Stéphane, Professeur associé des universités mi-temps) PHILOSPHIE 17

L. Coz and P. , PR) (17ème section)

H. Autorité and D. Santé, Dépistage et prévention du cancer du col de l'utérus [Internet] Disponible sur : https, 2013.

S. Lanta, J. Gondry, and J. Boulanger, Dépistage et cancer du col : l'état des lieux en France. Dans : Collège national des gynécologues et obstétriciens français Extrait des mises à jour en gynécologie médicale, Disponible sur, pp.657-676, 2010.

H. Autorité and D. Santé, État des lieux et recommandations pour le dépistage du cancer du col de l'utérus en France, p.2010

N. Duport, D. Serra, H. Goulard, and J. Bloch, Quels facteurs influencent la pratique du dépistage des cancers féminins en France ? Revue d'Épidémiologie et de Santé Publique, pp.303-316, 2008.

E. Bernard, O. Saint-lary, and L. Haboubi, D??pistage du cancer du col de l'ut??rus?: connaissances et participation des femmes, Sant?? Publique, vol.25, issue.3, pp.255-262, 2013.
DOI : 10.3917/spub.253.0255

L. Ramjan, A. Cotton, M. Algoso, and K. Peters, Barriers to breast and cervical cancer screening for women with physical disability: A review, Women & Health, vol.40, issue.9, pp.141-56, 2016.
DOI : 10.2105/AJPH.2008.150318

W. Horner-johnson, K. Dobbertin, E. Andresen, and L. Iezzoni, Breast and Cervical Cancer Screening Disparities Associated with Disability Severity, Women's Health Issues, vol.24, issue.1, 2014.
DOI : 10.1016/j.whi.2013.10.009

E. Andresen, J. Peterson-besse, G. Krahn, E. Walsh, W. Horner-johnson et al., Pap, Mammography, and Clinical Breast Examination Screening Among Women with Disabilities: A Systematic Review, Women's Health Issues, vol.23, issue.4, pp.205-214, 2013.
DOI : 10.1016/j.whi.2013.04.002

M. Martinez-huedo, A. Lopez-de-andres, V. Hernandez-barrera, P. Carrasco-garrido, M. Hernandez et al., Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between, Diabetes Metab, 2006.

P. Constantinou, R. Dray-spira, and G. Menvielle, Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey, BMC Cancer, vol.1, issue.2, p.255, 2016.
DOI : 10.1097/00001648-199003000-00011

URL : https://hal.archives-ouvertes.fr/hal-01297855

C. Kiefe, E. Funkhouser, M. Fouad, and D. May, Chronic disease as a barrier to breast and cervical cancer screening, Journal of General Internal Medicine, vol.46, issue.1, pp.357-65, 1998.
DOI : 10.1097/00005650-199611000-00004

L. Jensen, A. Pedersen, B. Andersen, M. Vestergaard, and P. Vedsted, Non-participation in breast cancer screening for women with chronic diseases and multimorbidity: a population-based cohort study, BMC Cancer, vol.12, issue.4, p.798, 2015.
DOI : 10.1186/1472-6947-12-38

B. Liu, O. Malley, J. Mori, M. Fagnan, L. Lieberman et al., The Association of Type and Number of Chronic Diseases with Breast, Cervical, and Colorectal Cancer Screening, The Journal of the American Board of Family Medicine, vol.27, issue.5, pp.669-81, 2014.
DOI : 10.3122/jabfm.2014.05.140005

S. Kim, S. Schneeweiss, J. Liu, E. Karlson, J. Katz et al., Biologic Disease-Modifying Antirheumatic Drugs and Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Rheumatoid Arthritis: A Cohort Study, Arthritis & Rheumatology, vol.11, issue.Suppl 2
DOI : 10.1038/nrrheum.2015.30

F. Aubin, M. Martin, E. Puzenat, N. Magy-bertrand, M. Segondy et al., Infection g??nitale ?? papillomavirus humain au cours des maladies auto-inflammatoires et/ou auto-immunes, Revue du Rhumatisme, vol.78, issue.4, pp.313-321, 2011.
DOI : 10.1016/j.rhum.2010.11.005

H. Wadström, T. Frisell, P. Sparén, J. Askling, . Artis et al., Do RA or TNF inhibitors increase the risk of cervical neoplasia or of recurrence of previous neoplasia? A nationwide study from Sweden, Annals of the Rheumatic Diseases, vol.63, issue.7, pp.1272-1280, 2016.
DOI : 10.1002/art.27758

R. Cordtz, L. Mellemkjaer, B. Glintborg, M. Hetland, and L. Dreyer, Malignant progression of precancerous lesions of the uterine cervix following biological DMARD therapy in patients with arthritis: Table??1, Annals of the Rheumatic Diseases, vol.66, issue.(Suppl), pp.1479-80, 2015.
DOI : 10.1136/annrheumdis-2012-201814

S. Slimani, C. Lukas, B. Combe, and J. Morel, Rituximab dans la polyarthrite rhumato??de et risque de cancer??: r??sultats d???une cohorte fran??aise, Revue du Rhumatisme, vol.78, issue.5, pp.427-457, 2011.
DOI : 10.1016/j.rhum.2011.01.007

C. Feldman and S. Kim, Should we target patients with autoimmune diseases for human papillomavirus vaccine uptake?, Expert Review of Vaccines, vol.51, issue.40, pp.931-935, 2014.
DOI : 10.1093/rheumatology/kes175

S. Kim and D. Solomon, Tumor necrosis factor blockade and the risk of viral infection, Nature Reviews Rheumatology, vol.43, issue.3, pp.165-74, 2010.
DOI : 10.7326/0003-4819-136-2-200201150-00020

S. Kim, R. Glynn, E. Giovannucci, S. Hernández-díaz, J. Liu et al., Risk of high-grade cervical dysplasia and cervical cancer in women with systemic inflammatory diseases: a population-based cohort study, Annals of the Rheumatic Diseases, vol.11, issue.(Suppl 5), pp.1360-1367, 2015.
DOI : 10.1186/1546-0096-11-29

A. Raposo, C. Tani, J. Costa, and M. Mosca, Human papillomavirus infection and cervical lesions in rheumatic diseases: a systematic review, Acta Reumatol Port, vol.41, issue.3, pp.184-90, 2016.

S. Sihvonen, M. Korpela, and P. Laippala, Death rates and causes of death in patients with rheumatoid arthritis: a population???based study, Scandinavian Journal of Rheumatology, vol.461, issue.9, pp.221-228, 2004.
DOI : 10.1136/ard.46.9.658

V. Goëb, M. Ardizzone, L. Arnaud, J. Avouac, A. Baillet et al., Conseils d???utilisation des traitements anti-TNF et recommandations nationales de bonne pratique labellis??es par la Haute Autorit?? de sant?? fran??aise, Revue du Rhumatisme, vol.80, issue.5, pp.459-66, 2013.
DOI : 10.1016/j.rhum.2013.08.004

J. Curtis, T. Arora, and P. Narongroeknawin, The delivery of evidence-based preventive care for older Americans with arthritis, Arthritis Research & Therapy, vol.12, issue.4, p.144, 2010.
DOI : 10.1186/ar3086

C. Maclean, R. Louie, B. Leake, D. Mccaffrey, H. Paulus et al., Quality of Care for Patients With Rheumatoid Arthritis, JAMA, vol.284, issue.8, pp.984-92, 2000.
DOI : 10.1001/jama.284.8.984

H. Kremers, M. Bidaut-russell, C. Scott, M. Reinalda, A. Zinsmeister et al., Preventive medical services among patients with rheumatoid arthritis, J Rheumatol, 2003.

S. Kim, S. Schneeweiss, J. Myers, J. Liu, and D. Solomon, No differences in cancer screening rates in patients with rheumatoid arthritis compared to the general population, Arthritis & Rheumatism, vol.295, issue.10, 2012.
DOI : 10.1001/jama.295.19.2275

D. Solomon, E. Karlson, and G. Curhan, Cardiovascular care and cancer screening in female nurses with and without rheumatoid arthritis, Arthritis Care & Research, vol.123, issue.3, pp.429-461, 2004.
DOI : 10.1001/jama.287.20.2659

B. Erik, Dépistage du cancer du col de l'utérus : connaissances et participation des femmes

N. Beltzer, F. Hamers, and N. Duport, Résultats finaux de l'évaluation du dépistage du cancer du col de l'utérus organisé dans 13 départements en France, Bull Epidémiol Hebd, issue.2- 3, pp.2010-201426, 2017.

L. Piana, F. Leandri, L. Retraite, L. Heid, P. Tamalet et al., auto-prélèvement vaginal à domicile pour recherche de papilloma virus à haut risque, Campagne expérimentale du département des Bouches-du-Rhône, Bulletin du Cancer, vol.98, issue.7, pp.723-731, 2011.